Moderna is actively continuing its study on a vaccine for bird flu, but has opted to restrict its research activities in the United States.
This decision coincides with the recent announcement that flu vaccinations are no longer mandatory for U.S. military personnel.
The ongoing developments in vaccine research highlight the complexities of public health strategies and regulatory environments.